vimarsana.com
Home
Live Updates
Gilead Sciences - Investigational Seladelpar Demonstrates Si
Gilead Sciences - Investigational Seladelpar Demonstrates Si
Gilead Sciences - Investigational Seladelpar Demonstrates Significant Improvements in Liver Disease Progression and Reduced Itching in Primary Biliary Cholangitis
FOSTER CITY - Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with...
Related Keywords
United Kingdom ,
Foster City ,
California ,
United States ,
Washington ,
Merdad Parsey ,
Jacquie Ross ,
Meaghan Smith ,
Gilead Company ,
Cymabay Therapeutics Inc ,
Gilead Sciences In Liver Disease ,
Gilead Sciences ,
Regulatory Agency ,
Nasdaq ,
Gilead Sciences Inc ,
University Of Miami ,
Exchange Commission ,
Drug Administration ,
European Medicines Agency ,
Bay Therapeutics ,
Presidential Plenary ,
Digestive Disease Week ,
Chief Medical Officer ,
New Drug Application ,
Child Pugh ,
Kingdom Medicines ,
Medicines Agency ,
Primary Biliary Cholangitis ,
Interim Results ,
Private Securities Litigation Reform Act ,
Quarterly Report ,
News Publishing ,